Fennec Pharmaceuticals (FENC) Amortizatization of Intangibles (2021 - 2025)

Fennec Pharmaceuticals (FENC) has 5 years of Amortizatization of Intangibles data on file, last reported at $27000.0 in Q4 2025.

• Quarterly Amortizatization of Intangibles fell 63.51% year-over-year to $27000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $65000.0 (down 52.9% YoY) and the FY2025 annual result came in at $65000.0, down 52.9% from the prior year.
• Amortizatization of Intangibles climbed to $27000.0 in Q4 2025, from $12000.0 in the prior quarter.
• In the past five years, Amortizatization of Intangibles ranged from a high of $74000.0 in Q4 2024 to a low of $1000.0 in Q4 2021.
• A 5-year average of $17937.5 and a median of $15000.0 in 2022 frame the typical range for Amortizatization of Intangibles.
• Annual changes were most pronounced in 2023 — Amortizatization of Intangibles jumped 1900.0% — and 2025, when it slumped 63.51%.
• Tracing FENC's Amortizatization of Intangibles over 5 years: stood at $1000.0 in 2021, then surged by 1400.0% to $15000.0 in 2022, then changed by 0.0% to $15000.0 in 2023, then soared by 393.33% to $74000.0 in 2024, then tumbled by 63.51% to $27000.0 in 2025.
• The last three Amortizatization of Intangibles figures came in at $27000.0 (Q4 2025), $12000.0 (Q3 2025), and $13000.0 (Q2 2025), per Business Quant data.